Колин Кэмпбелл - Китайское исследование - обновленное и расширенное издание. Классическая книга о здоровом питании [litres]

Moynihan R. “Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2. Disentanglement.” BMJ 326 (2003): 1193–1196.

Lexchin J. “Interactions between physicians and the pharmaceutical industry: what does the literature say?” Can. Med. Assoc. J. 149 (1993): 1401–1407.

Lexchin J. “What information do physicians receive from pharmaceutical representatives?” Can. Fam. Physician 43 (1997): 941–945.

Baird P. “Getting it right: industry sponsorship and medical research.” Can. Med. Assoc. Journ. 168 (2003): 1267–1269.

Smith R. “Medical journals and pharmaceutical companies: uneasy bedfellows.” BMJ 326 (2003): 1202–1205.

Angell M. “Is academic medicine for sale?” New Engl. J. Med. 342 (2000): 1516–1518.

Chopra S. S. “Industry funding of clinical trials: benefit or bias?” JAMA 290 (2003): 113–114.

Baird P. “Getting it right: industry sponsorship and medical research.” Can. Med. Assoc. Journ. 168 (2003): 1267–1269.

Healy D. “In the grip of the python: conflicts at the university-industry interface.” Sci. Engineering Ethics 9 (2003): 59–71.

Baird P. “Getting it right: industry sponsorship and medical research.” Can. Med. Assoc. Journ. 168 (2003): 1267–1269.

Chopra S. S. “Industry funding of clinical trials: benefit or bias?” JAMA 290 (2003): 113–114.

Olivieri N. F. “Patients’ health or company profits? The commercialization of academic research.” Sci. Engineering Ethics 9 (2003): 29–41.

Healy D. “In the grip of the python: conflicts at the university-industry interface.” Sci. Engineering Ethics 9 (2003): 59–71.

Smith R. “Medical journals and pharmaceutical companies: uneasy bedfellows.” BMJ 326 (2003): 1202–1205.

Olivieri N. F. “Patients’ health or company profits? The commercialization of academic research.” Sci. Engineering Ethics 9 (2003): 29–41.

Healy D. “In the grip of the python: conflicts at the university-industry interface.” Sci. Engineering Ethics 9 (2003): 59–71.

Angell M. “Is academic medicine for sale?” New Engl. J. Med. 342 (2000): 1516–1518.

Angell M. “Is academic medicine for sale?” New Engl. J. Med. 342 (2000): 1516–1518.

Johnson L. “Schools report research interest conflicts.” Ithaca Journal, 24 октября 2002 г.: 3A.

Agovino T. “Prescription use by children multiplying, study says.” Ithaca Journal, September 19, 2002: 1A.

Associated Press. “Survey: many guidelines written by doctors with ties to companies.” Ithaca Journal, 12 февраля 2002 г.

Weiss R. “Correctly prescribed drugs take heavy toll; millions affected by toxic reactions.” Washington Post, 15 апреля 1998 г.: A01.

Lasser K. E., Allen P. D., Woolhandler S. J., et al. “Timing of new black box warnings and withdrawals for prescription medications.” JAMA 287 (2002): 2215–2220.

Lazarou J., Pomeranz B., and Corey P. N. “Incidence of adverse drug reactions in hospitalized patients.” JAMA 279 (1998): 1200–1205.

Adams K. M., Kohlmeier M., Zeisel S. H. “Nutrition education in U.S. medical schools: latest update of a national survey.” Acad. Med. 85 (2010): 1537–1542.

Giocomino B., Cram P., Vaughan-Sarrazin M., Girotra S. “Abstract 208: Association of hospital prices for coronary artery bypass graft surgery with hospital quality and reimbursement.” Circulation: Cardiovascular Quality and Outcomes 8 (2015): A208 (poster session).

Shanafelt T. D., Hasan O., Dyrbye L. N., et al. “Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014.” Mayo Clin. Proc. 90 (2015): 1600–1613.

Национальный центр образовательной статистики, «Основные факты» / “Fast Facts.” Информация по состоянию на 3 сентября 2016 г., на сайте nces.ed.gov/fastfacts/.

Национальные институты здравоохранения, «О Национальных институтах здравоохранения. Чем мы занимаемся. Бюджет» / National Institutes of Health. “About NIH: What We Do: Budget.” 4 апреля 2016 г. Информация по состоянию на 3 сентября 2016 г., на сайте www.nih.gov/about-nih/what-we-do/budget.

Министерство сельского хозяйства США, Национальный институт продовольствия и сельского хозяйства, «Расширение» / U.S. Department of Agriculture, National Institute of Food and Agriculture. “Extension.” Информация по состоянию на 3 сентября 2016 г., на сайте nifa.usda.gov/extension.

Центр СМИ и демократии / Center for Media and Democracy. “SourceWatch: Physicians Committee for Responsible Medicine: Court Rules against USDA Secrecy & Conflicts of Interest.” Последнее обновление 12 марта 2015 г. Информация по состоянию на 3 сентября 2016 г., на сайте www.sourcewatch.org/index.php/Physicians_Committee_for_Responsible_Medicine#Court_rules_against_USDA_secrecy_.26_conflicts_of_interest.

Национальный ученый совет, «Диета, питание и рак» / National Research Council. Diet, Nutrition, and Cancer. Washington, DC: National Academy Press, 1982.

Kingkade T. “Tenure decline: Inside Higher Ed survey finds provosts relying on non-tenured faculty.” Huffington Post, 23 января 2013 г. На сайте www.huffingtonpost.com/2013/01/23/tenure-decline_n_2537418.html.

Pankin R., and Weiss C. “Part-time faculty in higher education: a selected annotated bibliography.” DigitalCommons@Providence. Публикации факультета социологии, 1 октября 2011 г. На сайте digitalcommons.providence.edu/cgi/viewcontent.cgi?article=1000&context=sociology_fac.

Kingkade T. “Tenure decline: Inside Higher Ed survey finds provosts relying on non-tenured faculty.” Huffington Post, 23 января 2013 г. На сайте www.huffingtonpost.com/2013/01/23/tenure-decline_n_2537418.html.

Washburn J. “Science’s worst enemy: corporate funding.” DiscoverMagazine.com, 11 октября 2007 г. На сайте discovermagazine.com/2007/oct/sciences-worst-enemy-private-funding.

Ассоциация американских колледжей и университетов, «Научное свободомыслие и педагогическая ответственность» / Association of American Colleges & Universities. “Academic freedom and educational responsibility.” 6 января 2006 г. На сайте www.aacu.org/about/statements/academic-freedom.